Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.3K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K
Timing and Consequences on Behavior01:08

Timing and Consequences on Behavior

393
In operant conditioning, the timing of reinforcement is crucial. For animals like rats and cats, immediate reinforcement (within a few seconds) is much more effective than delayed reinforcement. For example, a food reward for a rat needs to follow within 30 seconds of pressing a bar to be effective. 
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
393
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

812
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
812
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

266
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
266
Characteristics of Practical Op Amps01:16

Characteristics of Practical Op Amps

863
A difference amplifier, a crucial component in numerous electronic devices, ideally amplifies only the difference-mode signal, which is the difference between two input signals. However, in practical circuits, the output voltage depends on both the differential gain and the common-mode gain.
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
863

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity in COPD: Revealed and Unrevealed Issues.

COPD·2017
Same author

Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial.

International journal of chronic obstructive pulmonary disease·2017
Same author

External validation of prediction models for time to death in potential donors after circulatory death.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.

International journal of chronic obstructive pulmonary disease·2017
Same author

Mindfulness-based stress reduction added to care as usual for lung cancer patients and/or their partners: A multicentre randomized controlled trial.

Psycho-oncology·2017
Same author

Zinc protoporphyrin/heme ratio as parameter of iron status in moderately preterm infants: natural course and associations in the first 4 months.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same journal

Global, Regional, and National Burden of COPD Attributable to Secondhand Smoke from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.

COPD·2026
Same journal

Upregulation of LncRNA MIR31HG in COPD Correlates with Disease Severity and Facilitates Inflammation via miR-342-3p.

COPD·2026
Same journal

Methodological Considerations in the Development of the AECOPD "Infection Score".

COPD·2026
Same journal

Barriers and Facilitators to Treatment Plan Adoption and Self-Management in People with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Search and Narrative Synthesis.

COPD·2026
Same journal

Airway Mucus Occlusions in Ex-Smokers with and Without COPD.

COPD·2026
Same journal

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

COPD·2026
See all related articles

Related Experiment Video

Updated: Feb 1, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Obesity in COPD: Comorbidities with Practical Consequences?

S Zewari1, L Hadi1, F van den Elshout1

  • 1a Department of Pulmonary Disease , Rijnstate hospital , Arnhem , Netherlands.

COPD
|December 5, 2018
PubMed
Summary
This summary is machine-generated.

Obesity is common in Chronic Obstructive Pulmonary Disease (COPD) patients, particularly in earlier stages. Obese COPD patients exhibit distinct comorbidities, with cardiovascular and metabolic conditions like hypertension and diabetes being more prevalent.

Keywords:
chronic obstructive pulmonary diseaseobesityprevalence

More Related Videos

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.4K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.5K

Related Experiment Videos

Last Updated: Feb 1, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.4K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.5K

Area of Science:

  • Pulmonary Medicine
  • Metabolic Disorders
  • Cardiovascular Health

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) and obesity frequently coexist, indicating a complex interplay.
  • Understanding the prevalence of obesity and its associated comorbidities in COPD patients is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of obesity within a secondary care COPD population.
  • To compare the comorbidity profiles of obese (COPD_OB) versus non-obese (COPD_NO) COPD patients.

Main Methods:

  • Retrospective analysis of 1654 COPD patients (≥18 years) from January to December 2015.
  • Categorization by Body Mass Index (BMI): underweight, normal weight, overweight, and obese (BMI ≥30.0 kg/m²).
  • Quantification of comorbidities using Charlson and COTE indices.

Main Results:

  • Obesity prevalence was 21.8% in the COPD population, less common in GOLD stage IV (10.1%) compared to GOLD I-III.
  • COPD_OB patients showed significantly higher rates of hypertension, diabetes mellitus, atrial fibrillation, and congestive heart failure.
  • COPD_NO patients had a higher prevalence of osteoporosis and lung cancer.

Conclusions:

  • Obesity is prevalent in COPD patients, particularly in GOLD stages I-II.
  • Obese COPD patients present with a distinct comorbidity profile, characterized by a higher burden of cardiovascular and metabolic diseases.
  • Physicians should prioritize screening for hypertension and diabetes in obese COPD patients.